| Document Date: 2012-01-27 02:34:57
Open Document File Size: 968,51 KBShare Result on Facebook
City Madrid / / Company Johnson & Johnson / Janssen Pharmaceutica NV / Centocor / Janssen Pharmaceutical Companies / Janssen-Cilag / Healthcare Corporation / Crucell / Tibotec / Janssen Janssen / Virco / Ortho Biotech / / Continent Africa / Europe / / Country Switzerland / Germany / Netherlands / Italy / South Africa / Belgium / France / United States / United Kingdom / Spain / India / Ireland / / Currency USD / EUR / / Event M&A / / IndustryTerm green energy / finance specialists / biotechnology / personalised treatment solutions / manufacturing sites / pharmaceutical / healthcare / energy / health care solutions / integrated care solutions / pharmaceutical sales / treatment of HIV / pharmaceutical research / sustainable solutions / technology / therapeutic solutions / internal auditing systems / / MedicalCondition chronic and burdensome diseases / inflammatory bowel disease / severe psoriasis / HIV / ankylosing spondylitis / rheumatoid arthritis / multiple myeloma patients tiresome trips / multiple myeloma treatments / hepatitis C / pandemic diseases / obesity / psoriasis / illness / advanced prostate cancer / heart diseases / Alzheimer’s dementia / cancer / schizophrenia / disease / rheumatoid and psoriatic arthritis / diabetes / prostate / colorectal cancer / HCV / pain / diseases / infectious diseases / HIV/AIDS / curable disease / METABOLISM Heart disease / disorders / bipolar disorder / tuberculosis / / Organization World Health Organisation / European Union / / Person Crucell / Bern Latina Madrid Toledo / Schaffhausen / Paul Janssen / / Position gifted and passionate scientist and entrepreneur / representative / / Product VELCADE / / ProvinceOrState New Brunswick / / Region Middle East / / Technology genomics / NEUROSCIENCE / biotechnology / / URL www.janssen-emea.com / /
SocialTag |
Janssen EMEA (Europe, the Middle East & Africa) Extraordinary efforts for